Reciprocal regulation of cholesterol and beta amyloid at the subcellular level in Alzheimer’s disease

Author： Posse de Chaves Elena  

Publisher： NRC Research Press

ISSN： 1205-7541

Source： Canadian Journal of Physiology and Pharmacology, Vol.90, Iss.6, 2012-06, pp. : 753-764

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Subcellular Injuries in Alzheimer’s Disease

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 4, 2014-06 ,pp. : 593-605

Bentham Science Publishers

Access to resources Recommend Favorite

Oxidative Stress and Amyloid Beta Toxicity in Alzheimer’s Disease: Intervention in a Complex Relationship by Antioxidants

By  

Current Medicinal Chemistry, Vol. 20, Iss. 37, 2013-11 ,pp. : 4648-4664

Bentham Science Publishers

Access to resources Recommend Favorite

Pyroglutamate-Modified Amyloid Beta Peptides: Emerging Targets for Alzheimer´s Disease Immunotherapy

By  

Current Neuropharmacology, Vol. 11, Iss. 5, 2013-09 ,pp. : 491-498

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibition of Amyloid-&bgr; Aggregation in Alzheimer's Disease

By  

Current Pharmaceutical Design, Vol. 20, Iss. 8, 2014-03 ,pp. : 1223-1243

Bentham Science Publishers

Access to resources Recommend Favorite

Electrochemistry of Alzheimer Disease Amyloid Beta Peptides

By  

Current Medicinal Chemistry, Vol. 25, Iss. 33, 2018-10 ,pp. : 4066-4083

Bentham Science Publishers

Access to resources Recommend Favorite